Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | LOW | NEE |
|---|---|---|
| Price | $188.43 | $76.24 |
| Change today | ▼ 1.53% | ▼ 1.01% |
| Market cap | $105.72B | $159.03B |
| Return, 3 months | -14.4% | -12.3% |
| Return, year to date | -20.7% | -3.0% |
| Return, 1 year | -25.3% | +6.2% |
| P/E (TTM) | 15.9 | 17.1 |
| P/B | -14.2 | 2.8 |
| P/E percentile vs own 5y | 12th | 15th |
| Dividend yield | 2.57% | 3.12% |
| Revenue growth (YoY, latest qtr) | +8.3% | +12.4% |
| Net profit growth (YoY) | +0.0% | +60.0% |
| Gross margin | 33.1% | 61.0% |
| Operating margin | 11.4% | 28.3% |
| Net margin | 7.3% | 32.4% |
| Return on equity | – | 17.2% |
| Analyst target vs. price | +35.5% | +33.4% |
| Analyst buy share | 71% | 64% |
| RSI (14) | 36 | 25 |
| 30-day volatility | 20.4% | 12.2% |
| Max drawdown, 1 year | -32.8% | -19.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.